SpringWorks Therapeutics Inc (NAS:SWTX)
$ 36.12 -0.08 (-0.22%) Market Cap: 2.68 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.71 GF Score: 40/100

Q1 2024 SpringWorks Therapeutics Inc Earnings Call Transcript

May 02, 2024 / 12:30PM GMT
Release Date Price: $43.35 (-7.45%)
Operator

Good morning. My name is Towanda, and I will be your conference operator today. At this time, I would like to welcome everyone. The SpringWorks Therapeutics first quarter 2024 earnings conference call. (Operator Instructions)

Thank you. I would now like to hand the conference over to Samantha Sandler, Senior Director of Investor Relations at SpringWorks Therapeutics Summit. You may now begin the conference.

Samantha Sandler
SpringWorks Therapeutics Inc - Senior Director of Investor Relations

Thank you and good morning, everyone. Welcome to SpringWorks Therapeutics first quarter 2024 earnings conference call. This morning, we issued a press release which outlines the topics we plan to discuss today you can access the press release as well as the slides that we'll be reviewing today by going to the Investors and Media section of our website at www.springworkstx.com.

Joining me today are Saqib Islam, Chief Executive Officer; Bhavesh Ashar, Chief Commercial Officer; Dr. Jim

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot